Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CORONADO BIOSCIENCES INC (to 4/27/2015)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 115 % -45.5%
Quick Ratio 11 % -12%
Debt-to-equity 861 % +103%
Return On Equity 691 %
Return On Assets -32.9 % -10.8%
Operating Margin -141 % +57.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 19.4 M shares -85.1%
Entity Public Float 52.9 M USD -20.3%
Common Stock, Value, Issued 19 K USD -85.4%
Weighted Average Number of Shares Outstanding, Basic 17.2 M shares +153%
Weighted Average Number of Shares Outstanding, Diluted 8.11 M shares +36.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 85.1 M USD +32.5%
Research and Development Expense 91.4 M USD -33.6%
Costs and Expenses 205 M USD -26.6%
Operating Income (Loss) -120 M USD +44.2%
Nonoperating Income (Expense) -17.5 M USD -340%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -154 M USD +28%
Income Tax Expense (Benefit) 521 K USD +16%
Net Income (Loss) Attributable to Parent -54.5 M USD +41%
Earnings Per Share, Basic -6.03 USD/shares +68.6%
Earnings Per Share, Diluted -8.47 USD/shares +47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.8 M USD -45.1%
Accounts Receivable, after Allowance for Credit Loss, Current 9.8 M USD -64.5%
Inventory, Net 10.6 M USD -20.3%
Assets, Current 117 M USD -42.4%
Property, Plant and Equipment, Net 6.13 M USD -49.7%
Operating Lease, Right-of-Use Asset 16.5 M USD -15.4%
Other Assets, Noncurrent 3.97 M USD +321%
Assets 165 M USD -37.5%
Accounts Payable, Current 41.8 M USD -36.5%
Accrued Liabilities, Current 76.4 M USD -27.5%
Liabilities, Current 87.7 M USD -32.3%
Deferred Income Tax Liabilities, Net 233 K USD
Operating Lease, Liability, Noncurrent 17.6 M USD -16.2%
Other Liabilities, Noncurrent 1.85 M USD +2.61%
Liabilities 169 M USD -30.8%
Retained Earnings (Accumulated Deficit) -710 M USD -8.31%
Stockholders' Equity Attributable to Parent 23 M USD -39.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -3.94 M USD -120%
Liabilities and Equity 165 M USD -37.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4 M USD +41.3%
Net Cash Provided by (Used in) Financing Activities 27.9 M USD +25.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 19.4 M shares -85.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.8 M USD -44.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66 M USD -42.5%
Deferred Tax Assets, Valuation Allowance 366 M USD +15.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 374 M USD +14.7%
Operating Lease, Liability 20.2 M USD -14.1%
Depreciation 1.76 M USD -45.1%
Payments to Acquire Property, Plant, and Equipment 63 K USD -97.7%
Lessee, Operating Lease, Liability, to be Paid 25.1 M USD -17.6%
Property, Plant and Equipment, Gross 15.4 M USD -39.6%
Operating Lease, Liability, Current 2.6 M USD +3.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.54 M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.8 M USD +3.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.85 M USD -29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.19 M USD -17.7%
Deferred Tax Assets, Operating Loss Carryforwards 211 M USD +6.6%
Preferred Stock, Shares Issued 3.43 M shares 0%
Deferred Federal Income Tax Expense (Benefit) 194 K USD
Preferred Stock, Shares Authorized 15 M shares 0%
Unrecognized Tax Benefits 3.2 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.24 M USD -9.27%
Operating Lease, Payments 920 K USD +5.02%
Additional Paid in Capital 733 M USD +5.75%
Preferred Stock, Shares Outstanding 3.43 M shares 0%
Current State and Local Tax Expense (Benefit) 254 K USD -43.4%
Current Federal Tax Expense (Benefit) 33 K USD
Amortization of Intangible Assets 814 K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 7.52 M USD -4.8%
Share-based Payment Arrangement, Expense 17.2 M USD -22.6%
Deferred State and Local Income Tax Expense (Benefit) 39 K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%